Showing 61-70 of 87 results for "".
Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-43/23860/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20433/Following Autoimmune Diseases Through Patient Interactive Diaries: Continuous Quality Improvement
https://practicaldermatology.com/topics/practice-management/following-autoimmune-diseases-through-patient-interactive-diaries-continuous-quality-improvement/20402/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-10/23206/Why Are Dermatologists Not Writing Biologics?
https://practicaldermatology.com/topics/practice-management/why-are-dermatologists-inoti-writing-biologics/23427/Biologics have been shown to be both safe and effective for a variety of indications, so why don’t more dermatologists prescribe them?Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-5/23092/Medical Education and Technology: Intertwined like the Rod of Asclepius
https://practicaldermatology.com/columns/clinical-focus-1/medical-education-and-technology-intertwined-like-the-rod-of-asclepius/23453/Staphylococcus aureus and Atopic Dermatitis: Unweaving a Tangled Web
https://practicaldermatology.com/topics/general-topics/staphylococcus-aureus-and-atopic-dermatitis-unweaving-a-tangled-web/22083/Though the relationship is not fully understood, it points the way to potential treatments.Which Probiotic for Which Disease? Part 1
https://practicaldermatology.com/topics/atopic-dermatitis/which-probiotic-for-which-disease-part-1/23550/Enhanced interest in probiotics means clinicians need to pick the best strain for common dermatologic conditions.- James R. Headley Joins ELEVAI LABS as Strategic Advisorhttps://practicaldermatology.com/news/james-r-headley-joins-elevai-labs-as-strategic-advisor-a-strategic-advisor/2461450/Cosmetic industry veteran James R. Headley is joining